Clinical Trial Update: Study of Lenvatinib (E7080) in Participants With Advanced Hepatocellular Carcinoma (HCC) [Phase 1, Phase 2]

View source ↗

Summary

This update summarizes the Phase 1/2 trial results of lenvatinib in adults with advanced hepatocellular carcinoma, with the study status completed and results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• LENVIMA (lenvatinib)

Snippet

Sponsor: Eisai Co., Ltd. | Conditions: Hepatocellular Carcinoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-02-01